Skip to main content
. 2018 Nov 19;16:216. doi: 10.1186/s12955-018-1041-5

Fig. 5.

Fig. 5

Response frequencies for the preferred formulation of deferasirox at week 2 (start of treatment) and end of treatment by treatment arm. Numbers indicate the number of patients in each response category; *n < 5 patients; DT, dispersible tablet; FCT, film-coated tablet